Corrigendum: Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma

Front Immunol. 2023 Dec 19:14:1352909. doi: 10.3389/fimmu.2023.1352909. eCollection 2023.

Authors

Mingming Hu^#^{1

2}, XuLiang Liao^#^{1

2}, Yi Tao^#^{1

2}, Yaohui Chen^{1

3}

Affiliations

¹ Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, China.
² Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
³ Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1285113.].

Keywords: adenovirus therapy; cancer therapy; oncolytic herpes simplex virus; oncolytic viruses; recurrent gliomas.

Copyright © 2023 Hu, Liao, Tao and Chen.

Publication types

Published Erratum